These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 19811235)
41. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives]. Simoncini T; Mannella P; Genazzani AR Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369 [TBL] [Abstract][Full Text] [Related]
42. Estrogen receptor deficiency leads to impaired endothelial nitric oxide production and premature coronary arteriosclerosis. Rubanyi GM Ann N Y Acad Sci; 2000 May; 902():302-6. PubMed ID: 10865852 [No Abstract] [Full Text] [Related]
43. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681 [TBL] [Abstract][Full Text] [Related]
44. Vasomotor and vascular effects of hormone replacement therapy. Ganz P Am J Cardiol; 2002 Jul; 90(1A):11F-16F. PubMed ID: 12106634 [TBL] [Abstract][Full Text] [Related]
45. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection. Mijatovic V; van der Mooren MJ; Stehouwer CD; Netelenbos JC; Kenemans P Gynecol Endocrinol; 1999 Apr; 13(2):130-44. PubMed ID: 10399059 [TBL] [Abstract][Full Text] [Related]
46. [Vascular protection with estrogen. In-vitro and in-vivo effects--mechanisms and clinical implication]. Barton M; Wright E; Dai-Do D; Yang Z; Espinosa E; Arnet U; Lüscher TF Praxis (Bern 1994); 1997 Jan; 86(5):129-37. PubMed ID: 9064730 [TBL] [Abstract][Full Text] [Related]
48. The role of estrogen and estrogen-related drugs in cardiovascular diseases. Ogita H; Node K; Kitakaze M Curr Drug Metab; 2003 Dec; 4(6):497-504. PubMed ID: 14683477 [TBL] [Abstract][Full Text] [Related]
52. Targeted basic research to highlight the role of estrogen and estrogen receptors in the cardiovascular system. Dworatzek E; Mahmoodzadeh S Pharmacol Res; 2017 May; 119():27-35. PubMed ID: 28119050 [TBL] [Abstract][Full Text] [Related]
53. [Impact of hormone replacement therapy on the cardiovascular system]. Shviro I; Leitersdorf E Harefuah; 1995 May; 128(9):561-6. PubMed ID: 7797159 [No Abstract] [Full Text] [Related]
54. Estrogen and vascular system: more questions for the future. Jovanović A; Jovanović S Cardiovasc Res; 1999 Apr; 42(1):9-11. PubMed ID: 10434990 [No Abstract] [Full Text] [Related]
55. Postmenopausal hormone replacement therapy and the vascular wall: epidemiology and clinical studies. Joswig M; Hach-Wunderle V; von Holst T; Nawroth PP Vasa; 2000 Nov; 29(4):243-51. PubMed ID: 11141646 [TBL] [Abstract][Full Text] [Related]